Wed 25 Nov 2009 | 20:49 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For Hollis-Eden Pharmaceuticals Inc

Hollis-Eden Pharmaceuticals Inc (HEPH.O) (Consolidated Issue listed on NASDAQ Global Market)

sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty · View HEPH on other exchanges

As of 3:59pm EST

0.52USD

Price Change

+0.04

Percent Change

+7.81%

Analyst Recommendations

Independent Research | Broker Research

Name	Age	Since	Current Position
Marsella, Robert	56	2004	Senior Vice President - Business Development and Marketing
Frincke, James	58	2009	President, Chief Executive Officer, Director
Zizza, Salvatore	63	2009	Non-Executive Chairman of the Board
Weber, Robert	58	2008	Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Operations
Hauer, Jerome	57	2004	Director
Sarni, Marc	50	2004	Director
Reading, Christopher	61	2008	Chief Scientific Officer
Stickney, Dwight	66	2008	Chief Medical Officer

Find out more about HEPH.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.